BPC-157 + TB-500 (10mg/10mg)

The BPC-157 + TB-500 Blend is a co-lyophilized dual-peptide research compound combining 10mg of Body Protection Compound-157 (a 15-amino acid pentadecapeptide, MW ~1,419 Da) with 10mg of Thymosin Beta-4 fragment (43 amino acids, MW ~4,921 Da) in a single sterile vial.

This combination has gained research interest due to the complementary mechanisms proposed for each peptide in preclinical models. BPC-157 research has focused on nitric oxide system modulation, growth factor receptor upregulation (VEGF, EGF), and FAK-paxillin pathway activation. TB-500 investigations have centered on G-actin sequestration, cytoskeletal dynamics, and cellular migration facilitation via the LKKTETQ binding domain. Researchers studying tissue repair cascades have explored whether these dual-pathway interactions may produce effects distinct from either compound alone in animal models.

Preclinical studies have examined the co-administration of these peptides in the context of wound healing kinetics, tendon and connective tissue biology, and inflammatory signaling cascades. The blend format provides researchers with a convenient single-vial preparation for studies requiring both compounds.

Viking Labs co-lyophilizes these peptides under controlled conditions at a USA-based cGMP facility. Each blend batch undergoes dual-analyte HPLC verification confirming 99%+ purity for both peptide components. Certificate of Analysis, batch serialization, and sterile fill are standard.

Storage: Store lyophilized blend at -20C. Reconstituted solution at 2-8C, use within 21 days. Avoid repeated freeze-thaw cycles.

For laboratory research use only. Not for human consumption.